Lakefront Biotherapeutics | GLPG - Ebitda

Keuangan

EUR

EUR 3.35B

EUR 135.95M

Biaya Penjualan

EUR 9.15M

EUR 2.31B

Kewajiban Lancar

EUR 70.32M

EUR 6.44M

Dividen - Hasil

0

EUR -43.51M

EUR -63.7M

1.34K

Eps Laba Per Saham

EUR -0.2

Modal Dan Cadangan

EUR 3.26B

Laba Kotor Pada Penjualan

EUR 1.68M

Beban Bunga Utang

EUR 1.72M

Pendapatan Bunga

EUR 13.56M

EUR 4.77M

Kapitalisasi Pasar

EUR 1.56B

Batas Pemasukan

EUR 2.11M

Biaya Operasional

EUR 55.62M

Laba Operasional

EUR -43.51M

Modal Saham Biasa

EUR 65.66M

Pe Harga Untuk Laba

2.68

Laba Sebelum Pajak

EUR 13.96M

Pendapatan Penjualan

EUR 12.11M

Beban Penjualan Dan Administrasi

EUR 22.51M

EUR 17.69M

Kreditur Perdagangan

EUR 66.35M

Debitur Perdagangan

EUR 149.47M

	Ebitda	Perubahan		Tanggal
argenx SE	USD 427M		22.88M	2026-03
AstraZeneca	USD 5.16B		510M	2026-06
Biogen	USD 649.7M		76.5M	2026-03
Genmab	DKK 401M		186M	2026-06
Gilead Sciences	USD 3.51B		489M	2026-03
GlaxoSmithKline	GBP 3.51B		734M	2026-06
GRIFOLS	EUR 473M		120M	2026-06
Hikma Pharmaceutical	USD 369M		84M	2024-12
Incyte	USD 778.57M		410.6M	2026-06
Merck	EUR 1.6B		69M	2026-06
Neurocrine Biosciences	USD 193.3M		25.1M	2026-03
Novartis	USD 6.48B		1.19B	2026-06
Roche Holding	CHF 13.43B		744M	2026-06
Sanofi	EUR 3.69B		375M	2026-06
UCB	EUR 1.6B		570M	2025-12
Vertex Pharmaceuticals	USD 1.33B		130.5M	2026-06